Table 1

Novel, breast-specific peak 13741 is associated with estrogen-receptor-positive and progesterone-receptor-positive cells and Grade 1 breast cancer

ER+

ER-

PR+

PR-

Grade 1

Grade 3

(n = 146)

(n = 33)

(n = 129)

(n = 50)

(n = 42)

(n = 41)

13741+

122

(83.6%)

5

(15.2%)

112

(86.8%)

15

(30.0%)

37

(88.1%)

12

(29.3%)

13741-

24

(16.4%)

28

(84.8%)

17

(13.2%)

35

(70.0%)

5

(11.9%)

29

(70.7%)

RNA in situ hybridization results for analyses correlating the expression of peak 13741. Numbers of samples are reported. Each test was significant by the Kruskal-Wallis rank sum test. +, staining in >30% of cells; -, staining in <10% of cells; ER, estrogen receptor; PR, progesterone receptor.

Brunner et al. Genome Biology 2012 13:R75   doi:10.1186/gb-2012-13-8-r75